EP0783516A4 - Marquage des anticorps au phosphore 32 pour le traitement du cancer - Google Patents

Marquage des anticorps au phosphore 32 pour le traitement du cancer

Info

Publication number: EP0783516A4
Authority: EP; European Patent Office
Prior art keywords: labeling; antibodies; phosphorus; cancer therapy; cancer
Prior art date: 1994-09-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP95932443A

Other languages

German (de)

English (en)

Other versions

EP0783516A1 (fr

Inventor

Shui-On Leung

Hans J Hansen

Gary L Griffiths

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Immunomedics Inc

Original Assignee

Immunomedics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-16

Filing date

1995-09-18

Publication date

1999-09-15

1995-09-18 Application filed by Immunomedics Inc filed Critical Immunomedics Inc

1997-07-16 Publication of EP0783516A1 publication Critical patent/EP0783516A1/fr

1999-09-15 Publication of EP0783516A4 publication Critical patent/EP0783516A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5412—IL-6
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/13—Labelling of peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Analytical Chemistry (AREA)
Cell Biology (AREA)
Zoology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

EP95932443A 1994-09-16 1995-09-18 Marquage des anticorps au phosphore 32 pour le traitement du cancer Withdrawn EP0783516A4 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US30810394A	1994-09-16	1994-09-16
US308103		1994-09-16
PCT/US1995/011405 WO1996008506A1 (fr)	1994-09-16	1995-09-18	Marquage des anticorps au phosphore 32 pour le traitement du cancer

Publications (2)

Publication Number	Publication Date
EP0783516A1 EP0783516A1 (fr)	1997-07-16
EP0783516A4 true EP0783516A4 (fr)	1999-09-15

Family

ID=23192557

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP95932443A Withdrawn EP0783516A4 (fr)	1994-09-16	1995-09-18	Marquage des anticorps au phosphore 32 pour le traitement du cancer

Country Status (6)

Country	Link
EP (1)	EP0783516A4 (fr)
JP (1)	JPH10511263A (fr)
AU (1)	AU3548895A (fr)
CA (1)	CA2200088A1 (fr)
IL (1)	IL115177A0 (fr)
WO (1)	WO1996008506A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5874540A (en) *	1994-10-05	1999-02-23	Immunomedics, Inc.	CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
CA2495825C (fr) *	2002-08-19	2015-03-17	Merck Patent Gesellschaft Mit Beschraenkter Haftung	Variants de l'allergene majeur phl p 1 provenant de fleole des pres
US7803372B2 (en)	2002-10-08	2010-09-28	Immunomedics, Inc.	Antibody therapy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993011796A1 (fr) *	1991-12-16	1993-06-24	British Technology Group Ltd	Ameliorations concernant le marquage radioactif des proteines

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5077195A (en) *	1985-03-01	1991-12-31	Board Of Reagents, The University Of Texas System	Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
US4923802A (en) *	1985-06-13	1990-05-08	Immunex Corporation	Peptide substrates for the detection, characterization and purification of protein kinase C
GB2186579B (en) *	1986-01-21	1990-07-25	Brian Maurice John Foxwell	Improvements relating to the radio-labelling of proteins
GB8906708D0 (en) *	1989-03-23	1989-05-10	Foxwell Brian M J	Improvements relating to the radiolabelling of proteins
GB8916806D0 (en) *	1989-07-22	1989-09-06	Univ Wales Medicine	Modified proteins
DE69233785D1 (de) *	1991-04-19	2010-07-08	Univ Washington	diert
US5366889A (en) *	1992-11-30	1994-11-22	The General Hospital Corporation	DNA encoding a protein-coupled receptor kinase

1995
- 1995-09-05 IL IL11517795A patent/IL115177A0/xx unknown
- 1995-09-18 WO PCT/US1995/011405 patent/WO1996008506A1/fr not_active Application Discontinuation
- 1995-09-18 JP JP8510254A patent/JPH10511263A/ja not_active Ceased
- 1995-09-18 EP EP95932443A patent/EP0783516A4/fr not_active Withdrawn
- 1995-09-18 CA CA002200088A patent/CA2200088A1/fr not_active Abandoned
- 1995-09-18 AU AU35488/95A patent/AU3548895A/en not_active Abandoned

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993011796A1 (fr) *	1991-12-16	1993-06-24	British Technology Group Ltd	Ameliorations concernant le marquage radioactif des proteines

Also Published As

Publication number	Publication date
JPH10511263A (ja)	1998-11-04
CA2200088A1 (fr)	1996-03-21
AU3548895A (en)	1996-03-29
IL115177A0 (en)	1995-12-31
EP0783516A1 (fr)	1997-07-16
WO1996008506A1 (fr)	1996-03-21

Publication	Publication Date	Title
ZA9811314B (en)	1999-06-14	Novel compounds and methods for synthesis and therapy
IL234696A (en)	2017-06-29	Anti-erbb2 antibodies for the treatment of cancer drugs.
IL131560A0 (en)	2001-01-28	Compounds for immunotherapy of prostate cancer and methods for their use
GB2318734B (en)	1999-12-01	Methods of preventing breast cancer
GB9410320D0 (en)	1994-07-13	Novel therapeutic method
GB9509572D0 (en)	1995-07-05	Cancer therapy
HUP9900011A3 (en)	1999-11-29	Use of protein gax for treating cancer
IL115177A0 (en)	1995-12-31	Phosphorus-32 labeling of antibodies for cancer therapy
GB9308166D0 (en)	1993-06-02	Cancer therapy
ZA953560B (en)	1996-01-11	Tumor localising photosensitising compounds
GB9703633D0 (en)	1997-04-09	Cancer therapy
GB2303066A9 (en)	1997-04-14	Magnetic therapy system
GB2312375B (en)	1998-02-25	Agents for treatment of cancer
ZA988451B (en)	1999-03-31	Novel compounds and methods for synthesis and therapy
GB9504415D0 (en)	1995-04-26	Novel treatments for cancer
GB9624800D0 (en)	1997-01-15	Methods of preventing breast cancer
IL120901A0 (en)	1997-09-30	Cancer therapy
GB9701876D0 (en)	1997-03-19	Cancer therapy
ZA981585B (en)	1998-09-04	Compounds for immunotherapy of prostate cancer and methods for their use
GB9416932D0 (en)	1994-10-12	Tumour specific photeoglycan
GB9417061D0 (en)	1994-10-12	Novel method of therapy
AU2003204079A1 (en)	2003-06-12	Novel compounds and methods for synthesis and therapy
GB9217270D0 (en)	1992-09-30	Tumour therapy
ZA95941B (en)	1995-10-09	Liphophilic carrier preparations
GB9526110D0 (en)	1996-02-21	Therapeutic compounds

Legal Events

Date	Code	Title	Description
1997-05-30	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1997-07-16	17P	Request for examination filed	Effective date: 19970415
1997-07-16	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1997-07-16	AX	Request for extension of the european patent	Free format text: LT PAYMENT 970415;LV PAYMENT 970415;SI PAYMENT 970415
1999-09-10	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
1999-09-15	A4	Supplementary search report drawn up and despatched	Effective date: 19990729
1999-09-15	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1999-09-15	RIC1	Information provided on ipc code assigned before grant	Free format text: 6C 07K 2/00 A, 6C 07K 4/00 B, 6C 07K 7/00 B, 6C 07K 1/13 B, 6C 07K 14/54 B, 6C 07K 16/30 B
1999-10-27	18D	Application deemed to be withdrawn	Effective date: 19990401